152 related articles for article (PubMed ID: 36583371)
1. Circadian rhythmicity of amyloid-beta-related molecules is disrupted in the choroid plexus of a female Alzheimer's disease mouse model.
Furtado A; Esgalhado AJ; Duarte AC; Costa AR; Costa-Brito AR; Carro E; Ishikawa H; Schroten H; Schwerk C; Gonçalves I; Arosa FA; Santos CRA; Quintela T
J Neurosci Res; 2023 Apr; 101(4):524-540. PubMed ID: 36583371
[TBL] [Abstract][Full Text] [Related]
2. The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.
Furtado A; Astaburuaga R; Costa A; Duarte AC; Gonçalves I; Cipolla-Neto J; Lemos MC; Carro E; Relógio A; Santos CRA; Quintela T
J Alzheimers Dis; 2020; 77(2):795-806. PubMed ID: 32741824
[TBL] [Abstract][Full Text] [Related]
3. Age, Sex Hormones, and Circadian Rhythm Regulate the Expression of Amyloid-Beta Scavengers at the Choroid Plexus.
Duarte AC; Furtado A; Hrynchak MV; Costa AR; Talhada D; Gonçalves I; Lemos MC; Quintela T; Santos CRA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957439
[TBL] [Abstract][Full Text] [Related]
4. Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.
González-Marrero I; Giménez-Llort L; Johanson CE; Carmona-Calero EM; Castañeyra-Ruiz L; Brito-Armas JM; Castañeyra-Perdomo A; Castro-Fuentes R
Front Cell Neurosci; 2015; 9():17. PubMed ID: 25705176
[TBL] [Abstract][Full Text] [Related]
5. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
Alvira-Botero X; Carro EM
Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
[TBL] [Abstract][Full Text] [Related]
6. Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina.
Carrero L; Antequera D; Alcalde I; Megias D; Ordoñez-Gutierrez L; Gutierrez C; Merayo-Lloves J; Wandosell F; Municio C; Carro E
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958666
[TBL] [Abstract][Full Text] [Related]
7. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
8. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
Kant S; Stopa EG; Johanson CE; Baird A; Silverberg GD
Fluids Barriers CNS; 2018 Dec; 15(1):34. PubMed ID: 30541599
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
11. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
12. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
[TBL] [Abstract][Full Text] [Related]
13. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
14. Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer's disease.
Bartolome F; Krzyzanowska A; de la Cueva M; Pascual C; Antequera D; Spuch C; Villarejo-Galende A; Rabano A; Fortea J; Alcolea D; Lleo A; Ferrer I; Hardy J; Abramov AY; Carro E
Sci Rep; 2020 Jun; 10(1):9391. PubMed ID: 32523019
[TBL] [Abstract][Full Text] [Related]
15. Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.
Gu H; Wei X; Monnot AD; Fontanilla CV; Behl M; Farlow MR; Zheng W; Du Y
Neurosci Lett; 2011 Feb; 490(1):16-20. PubMed ID: 21167913
[TBL] [Abstract][Full Text] [Related]
16. Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer's disease.
Bolos M; Spuch C; Ordoñez-Gutierrez L; Wandosell F; Ferrer I; Carro E
Cell Mol Life Sci; 2013 Aug; 70(15):2787-97. PubMed ID: 23455075
[TBL] [Abstract][Full Text] [Related]
17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
18. Importance of extracellular vesicle secretion at the blood-cerebrospinal fluid interface in the pathogenesis of Alzheimer's disease.
Vandendriessche C; Balusu S; Van Cauwenberghe C; Brkic M; Pauwels M; Plehiers N; Bruggeman A; Dujardin P; Van Imschoot G; Van Wonterghem E; Hendrix A; Baeke F; De Rycke R; Gevaert K; Vandenbroucke RE
Acta Neuropathol Commun; 2021 Aug; 9(1):143. PubMed ID: 34425919
[TBL] [Abstract][Full Text] [Related]
19. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
